Data exists throughout every manufacturing business. It's hidden inside machines, unutilized and waiting to be harnessed.

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

Zydus Lifesciences Ltd. plans to enter the global biologics contract development and manufacturing organization (CDMO) ...

Frontage Laboratories, Inc. officially unveiled its newest Contract Research, Development and Manufacturing Organization (CRDMO) facility during a grand open house event held on May 22, 2025, at its ...